β-Amyloid (25-35) CAS NO.131602-53-4

β-Amyloid (25-35) CAS NO.131602-53-4

β-Amyloid (25-35) CAS NO.131602-53-4

β-Amyloid (25-35) CAS NO.131602-53-4

β-Amyloid (25-35) CAS NO.131602-53-4

β-Amyloid (25-35) (CAS NO. 131602-53-4) is a synthetic peptide fragment corresponding to amino acid residues 25-35 of the full-length human amyloid-β protein (Aβ). This highly cytotoxic 11-amino acid sequence (GSNKGAIIGLM) is considered the core neurotoxic domain of Aβ. It is widely used in neuroscience research as a standardized, potent inducer of neurotoxicity, oxidative stress, and apoptosis to model key aspects of Alzheimer's disease (AD) pathology in vitro and in vivo.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
 β-Amyloid (25-35)
CAS NO.
131602-53-4
Appearance
White to off-white lyophilized powder
Molecular Formula
C₄₅H₆₅N₁₃O₁₄S
Molecular Weight
 1060.15g/mol
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in DMSO (≥10 mg/mL); for aqueous solutions, prepare a stock solution in DMSO first, then dilute with buffer . Insoluble in water directly.

Endotoxin< 1.0 EU/mg
Biological Activity
-20°C for long-term storage ; avoid repeated freeze-thaw cycles. Store as aliquots in sealed vials, protected from light and moisture.
Storage Conditions
Store at -20°C to -80°C in a dry, dark, sealed environment; avoid repeated freeze‑thaw cycles.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

β-Amyloid (25-35) exerts its neurotoxic effects through multiple, convergent pathways:
  1. Membrane Disruption & Pore Formation: The fragment, especially in its aggregated form, can interact with and disrupt neuronal cell membranes, potentially forming cation-selective ion channels or pores. This leads to dysregulated calcium (Ca²⁺) and potassium (K⁺) ion homeostasis.
  2. Induction of Oxidative Stress: It directly and indirectly promotes the generation of reactive oxygen species (ROS), overwhelming cellular antioxidant defenses and damaging lipids, proteins, and DNA.
  3. Mitochondrial Dysfunction: The peptide targets mitochondria, inducing permeability transition pore (MPTP) opening, reducing membrane potential, and impairing ATP production, ultimately triggering the intrinsic apoptotic pathway.
  4. Activation of Pro-apoptotic Pathways: It activates key enzymes like caspase-3 and influences signaling pathways (e.g., p38 MAPK, JNK) that lead to programmed cell death.
  5. Inflammation: It can activate microglia, the brain's immune cells, leading to the release of pro-inflammatory cytokines that exacerbate neuronal damage. 

     2.PRODUCT INDICATIONS

 This product is primarily indicated for neuroscience and neurodegenerative disease research. Key applications include:
  • Alzheimer's Disease Modeling: As a standard toxin to induce AD-like pathology in cell cultures (primary neurons, neuronal cell lines) and in animal models (rats, mice) via intracerebral injection.
  • Neurotoxicity & Neuroprotection Assays: Screening and testing the efficacy of potential neuroprotective compounds, antioxidants, and therapeutic agents by assessing their ability to counteract Aβ(25-35)-induced damage.
  • Mechanistic Studies: Investigating the molecular and cellular mechanisms underlying amyloid toxicity, including oxidative stress, calcium dysregulation, apoptosis, and mitochondrial dysfunction.
  • Drug Discovery: Used in high-throughput screening platforms to identify novel inhibitors of Aβ aggregation or toxicity for AD treatment.


3.CLINICAL EFFICACY OF PRODUCT

β-Amyloid (25-35) is a research neurotoxin, not a therapeutic. It has no clinical efficacy for treatment. Its immense value lies in its role as a critical and reliable research tool.
  • Validation in Preclinical Research: It has been used in thousands of studies to validate the pathological relevance of the Aβ peptide and to model specific facets of AD. Many compounds showing neuroprotective effects against Aβ(25-35) in preclinical models have advanced to further stages of AD drug development.
  • Standardization: It provides a consistent, well-characterized insult to neuronal systems, allowing for the comparison of results across different laboratories and studies.
  • Foundation for Therapeutic Strategies: Research using this fragment has been instrumental in identifying the toxic pathways (e.g., oxidative stress, calcium overload) that are now major targets for the development of novel Alzheimer's therapeutics.


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.